biotech · Rheumatoid Arthritis · Pharmacokinetics · XBIT
XBiotech Germany
XBiotech Germany GmbH
BBT Biotech is a biotech organization headquartered in Baesweiler, DE. It trades on NYSE under ticker XBIT. Primary therapeutic focus areas include Rheumatoid Arthritis, Pharmacokinetics, Staphylococcus Aureus Bacteremia
Baesweiler, DE HQ
30 Employees
Public company Type
XBIT · NYSE Ticker
Company details
- Status
- Public
- HQ
- Baesweiler, DE
- Employees
- 30
- Programs
- 8
- Drugs
- 6
- Patents
- 31
Natrunix 400 mg
Phase 2 · mab · Rheumatoid Arthritis
Natrunix 400 mg for Rheumatoid Arthritis is a Phase 2 program (mab) at XBiotech Germany GmbH with 1 ClinicalTrials.gov record(s).
Internal code PT067
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- XBiotech Germany GmbH
- Phase
- Phase 2
- Modality
- mab
- Indication
- Rheumatoid Arthritis
- Status
- active
- Trials
- 1